Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc D Jacobs

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Bioorganic & Medicinal Chemistry Letters|May 6, 2009
Structure-based design of 3-aryl-6-amino-triazolo[4,3-b]pyridazine inhibitors of Pim-1 kinaseRon Grey, Albert C Pierce, Guy W Bemis, et al.
Clinical and Experimental Pharmacology & Physiology|January 22, 2005
Functional imaging: new views on lens structure and functionPaul J Donaldson, Angus C Grey, B Rachelle Merriman-Smith, et al.
Bioorganic & Medicinal Chemistry Letters|August 8, 2018
ROCK inhibitors 3: Design, synthesis and structure-activity relationships of 7-azaindole-based Rho kinase (ROCK) inhibitorsUpul K Bandarage, Jingrong Cao, Jon H Come, et al.
Antimicrobial Agents and Chemotherapy|December 31, 2014
Preclinical activity of VX-787, a first-in-class, orally bioavailable inhibitor of the influenza virus polymerase PB2 subunitRandal A Byrn, Steven M Jones, Hamilton B Bennett, et al.
ACS Medicinal Chemistry Letters|February 16, 2017
Novel 2-Substituted 7-Azaindole and 7-Azaindazole Analogues as Potential Antiviral Agents for the Treatment of InfluenzaUpul K Bandarage, Michael P Clark, Emanuele Perola, et al.
ACS Medicinal Chemistry Letters|February 16, 2017
Discovery of Novel, Orally Bioavailable β-Amino Acid Azaindole Inhibitors of Influenza PB2Luc J Farmer, Michael P Clark, Michael J Boyd, et al.
Journal of Medicinal Chemistry|May 31, 2018
Design and Synthesis of a Novel Series of Orally Bioavailable, CNS-Penetrant, Isoform Selective Phosphoinositide 3-Kinase γ (PI3Kγ) Inhibitors with Potential for the Treatment of Multiple Sclerosis (MS)Jon H Come, Philip N Collier, James A Henderson, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Bioorganic & Medicinal Chemistry Letters|May 6, 2009
Structure-based design of 3-aryl-6-amino-triazolo[4,3-b]pyridazine inhibitors of Pim-1 kinaseRon Grey, Albert C Pierce, Guy W Bemis, et al.
Clinical and Experimental Pharmacology & Physiology|January 22, 2005
Functional imaging: new views on lens structure and functionPaul J Donaldson, Angus C Grey, B Rachelle Merriman-Smith, et al.
Bioorganic & Medicinal Chemistry Letters|August 8, 2018
ROCK inhibitors 3: Design, synthesis and structure-activity relationships of 7-azaindole-based Rho kinase (ROCK) inhibitorsUpul K Bandarage, Jingrong Cao, Jon H Come, et al.
Antimicrobial Agents and Chemotherapy|December 31, 2014
Preclinical activity of VX-787, a first-in-class, orally bioavailable inhibitor of the influenza virus polymerase PB2 subunitRandal A Byrn, Steven M Jones, Hamilton B Bennett, et al.
ACS Medicinal Chemistry Letters|February 16, 2017
Novel 2-Substituted 7-Azaindole and 7-Azaindazole Analogues as Potential Antiviral Agents for the Treatment of InfluenzaUpul K Bandarage, Michael P Clark, Emanuele Perola, et al.
ACS Medicinal Chemistry Letters|February 16, 2017
Discovery of Novel, Orally Bioavailable β-Amino Acid Azaindole Inhibitors of Influenza PB2Luc J Farmer, Michael P Clark, Michael J Boyd, et al.
Journal of Medicinal Chemistry|May 31, 2018
Design and Synthesis of a Novel Series of Orally Bioavailable, CNS-Penetrant, Isoform Selective Phosphoinositide 3-Kinase γ (PI3Kγ) Inhibitors with Potential for the Treatment of Multiple Sclerosis (MS)Jon H Come, Philip N Collier, James A Henderson, et al.
Pageof 3